更新版 1-克罗格将向 Elevance Health 的 CarelonRx 出售专科药房业务

Reuters03-19

((自动化翻译由路透提供，请见免责声明 )) (补充交易细节和背景)

路透社3月18日 - 杂货商克罗格周一表示，已就向美国医疗保险公司 Elevance Health 旗下的CarelonRx出售其专业药房业务达成最终协议。

交易的财务条款没有披露。

该零售商的专科药房业务为需要复杂护理的慢性病患者提供服务。

克罗格专科药房与克罗格家族的其他药房（包括店内零售药房和 The Little Clinics）是分开的，后者不在交易之列。

预计该交易将于2024 年下半年完成，但需满足惯例成交条件并获得监管部门批准。预计该交易不会影响克罗格公司 2024 年的财政预测。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2420238231?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-03-19 04:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2420238231","market":"us","top_or_hot":-1,"title":"更新版 1-克罗格将向 Elevance Health 的 CarelonRx 出售专科药房业务","media":"Reuters","content":"<html><body><p>((自动化翻译由路透提供，请见免责声明 )) (补充交易细节和背景)</p><p>    路透社3月18日 - 杂货商<a href=\"https://laohu8.com/S/KR\">克罗格</a>  周一表示，已就向美国医疗保险公司 <a href=\"https://laohu8.com/S/ELV\">Elevance Health</a>  旗下的CarelonRx出售其专业药房业务达成最终协议。</p><p>     交易的财务条款没有披露。</p><p>该零售商的专科药房业务为 需要复杂护理的慢性病患者提供服务 。 </p><p>克罗格专科药房与克罗格家族的其他药房（包括店内零售药房和 The Little Clinics）是分开的，后者不在交易之列。 </p><p>预计该交易 将于2024 年下半年完成，但需 满足惯例成交条件并获得 监管部门批准  。 预计该 交易不会影响克罗格公司 2024 年的财政预测。</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>更新版 1-克罗格将向 Elevance Health 的 CarelonRx 出售专科药房业务</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n更新版 1-克罗格将向 Elevance Health 的 CarelonRx 出售专科药房业务\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-19 04:48 北京时间&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>((自动化翻译由路透提供，请见免责声明 )) (补充交易细节和背景)    路透社3月18日 - 杂货商克罗格  周一表示，已就向美国医疗保险公司 Elevance Health  旗下的CarelonRx出售其专业药房业务达成最终协议。     交易的财务条款没有披露。该零售商的专科药房业务为 需要复杂护理的慢性病患者提供服务 。 克罗格专科药房与克罗格家族的其他药房（包括店内零售药房和 The...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1023059063.AUD","symbol_name":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2420238231","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2420238231","pubTimestamp":1710794911,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"     路透社3月18日 - 杂货商克罗格  周一表示，已就向美国医疗保险公司 Elevance Health  旗下的CarelonRx出售其专业药房业务达成最终协议。交易的财务条款没有披露。该零售商的专科药房业务为 需要复杂护理的慢性病患者提供服务 。克罗格专科药房与克罗格家族的其他药房是分开的，后者不在交易之列。预计该交易 将于2024 年下半年完成，但需 满足惯例成交条件并获得 监管部门批准  。预计该 交易不会影响克罗格公司 2024 年的财政预测。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU0312595415.SGD":"Schroder ISF Global Climate Change Equity A Acc SGD","BK4532":"文艺复兴科技持仓","SG9999001077.SGD":"United International Growth Fund SGD","LU2430703251.USD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4\" (USD) INC","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","LU0640476718.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","ELV":"Elevance Health","LU0048573561.USD":"FIDELITY AMERICA \"A\" (USD) INC","LU0061474960.USD":"天利环球焦点基金AU Acc","BK4585":"ETF&股票定投概念","LU1670628061.USD":"M&G (LUX) NORTH AMERICAN DIVIDEND \"A\" (USD) INC","LU1280957306.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQUITIES \"AUP\" (USD) INC","BK4533":"AQR资本管理(全球第二大对冲基金)","SG9999004303.SGD":"Nikko AM Shenton Global Opportunities SGD","LU2592432038.USD":"WELLINGTON MULTI-ASSET HIGH INCOME \"A\" (USD) ACC","LU0058720904.USD":"联博国际健康护理基金A","LU1670627923.USD":"M&G (LUX) NORTH AMERICAN DIVIDEND \"A\" (USD) ACC","LU0251142724.SGD":"Fidelity America A-SGD","LU1489326972.SGD":"First Eagle Amundi International AHS-MD SGD-H","BK4113":"食品零售","BK4559":"巴菲特持仓","BK4588":"碎股","LU0882574055.USD":"富达全球健康医疗A ACC","LU2505996681.GBP":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4H\" (GBPHDG) INC","BK4154":"管理型保健护理","LU1720051017.SGD":"Allianz Global Artificial Intelligence AT Acc H2-SGD","LU2505996509.AUD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4H\" (AUDHDG) INC","LU0122379950.USD":"贝莱德世界健康科学A2","SGXZ23171101.USD":"NIKKO AM SHENTON GLOBAL OPPORTUNITIES (USD) ACC","LU0985489474.SGD":"First Eagle Amundi International AHS-C SGD-H","LU1548497426.USD":"安联环球人工智能AT Acc","LU0878866978.SGD":"First Eagle Amundi International AHS-QD SGD-H","BK4504":"桥水持仓","KR":"克罗格","LU0957791311.USD":"THREADNEEDLE (LUX) GLOBAL FOCUS \"ZU\" (USD) ACC","LU1815333072.USD":"THREADNEEDLE (LUX) GLOBAL FOCUS \"AUP\" (USD) INC","LU0742534661.SGD":"Fidelity America A-SGD (hedged)","LU0211331839.USD":"FRANKLIN MUTUAL GLB DISCOVERY \"A\" (USD) ACC","LU0433182093.SGD":"First Eagle Amundi International AS-C SGD","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","LU0557290698.USD":"施罗德环球可持续增长基金","LU1720051108.HKD":"ALLIANZ GLOBAL ARTIFICIAL INTELLIGENCE \"AT\" (HKD) ACC","LU0234570918.USD":"高盛全球核心股票组合Acc Close","LU0068578508.USD":"First Eagle Amundi International Cl AU-C USD","LU2430703095.HKD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4\" (HKD) INC","LU2357305700.SGD":"Allianz Global Artificial Intelligence ET H2-SGD","LU2430703178.SGD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4H\" (SGDHDG) INC"},"translate_title":"Update 1-Kroger will sell specialist pharmacy business to CarelonRx of Elevance Health","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ELV":1,"KR":1},"content_text":"((自动化翻译由路透提供，请见免责声明 )) (补充交易细节和背景)    路透社3月18日 - 杂货商克罗格  周一表示，已就向美国医疗保险公司 Elevance Health  旗下的CarelonRx出售其专业药房业务达成最终协议。     交易的财务条款没有披露。该零售商的专科药房业务为 需要复杂护理的慢性病患者提供服务 。 克罗格专科药房与克罗格家族的其他药房（包括店内零售药房和 The Little Clinics）是分开的，后者不在交易之列。 预计该交易 将于2024 年下半年完成，但需 满足惯例成交条件并获得 监管部门批准  。 预计该 交易不会影响克罗格公司 2024 年的财政预测。","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2420238231"}